ATE191348T1 - Wundverbände - Google Patents

Wundverbände

Info

Publication number
ATE191348T1
ATE191348T1 AT94902028T AT94902028T ATE191348T1 AT E191348 T1 ATE191348 T1 AT E191348T1 AT 94902028 T AT94902028 T AT 94902028T AT 94902028 T AT94902028 T AT 94902028T AT E191348 T1 ATE191348 T1 AT E191348T1
Authority
AT
Austria
Prior art keywords
pct
chemically modified
modified polymer
date jun
sec
Prior art date
Application number
AT94902028T
Other languages
English (en)
Inventor
Michael Fowler
Thomas Richard Burrow
Terence Dudley Turner
Ryszard Jan Schmidt
Lip Yong Chung
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cardiff filed Critical Univ Cardiff
Application granted granted Critical
Publication of ATE191348T1 publication Critical patent/ATE191348T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Surgical Instruments (AREA)
AT94902028T 1992-12-08 1993-12-03 Wundverbände ATE191348T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929225581A GB9225581D0 (en) 1992-12-08 1992-12-08 Wound dressings
PCT/GB1993/002490 WO1994013333A1 (en) 1992-12-08 1993-12-03 Wound dressings

Publications (1)

Publication Number Publication Date
ATE191348T1 true ATE191348T1 (de) 2000-04-15

Family

ID=10726264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94902028T ATE191348T1 (de) 1992-12-08 1993-12-03 Wundverbände

Country Status (9)

Country Link
US (1) US5667501A (de)
EP (1) EP0673262B1 (de)
JP (1) JPH08503869A (de)
AT (1) ATE191348T1 (de)
AU (1) AU679954B2 (de)
CA (1) CA2151246C (de)
DE (1) DE69328308D1 (de)
GB (2) GB9225581D0 (de)
WO (1) WO1994013333A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612321A (en) † 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
US5861149A (en) * 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US6699672B1 (en) * 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US20030161823A1 (en) * 1998-08-31 2003-08-28 Neta Ilan Therapeutic and cosmetic uses of heparanases
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
AU752255B2 (en) * 1998-10-23 2002-09-12 Polyheal Ltd. Compositions of microspheres for wound healing
CA2350628A1 (en) * 1998-11-12 2000-05-18 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
AU2878600A (en) * 1999-03-01 2000-09-21 Hadasit Medical Research Services & Development Company Ltd Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
GB0107653D0 (en) * 2001-03-27 2001-05-16 Bristol Myers Squibb Co Wound dressing
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
US7101862B2 (en) * 2001-12-31 2006-09-05 Area Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
GB2386900B (en) * 2002-03-25 2006-11-01 Johnson & Johnson Medical Ltd Use in wound dressings of chemically modified polysaccharides
GB2386899B (en) * 2002-03-25 2005-10-26 Johnson & Johnson Medical Ltd Wound dressings comprising chemically modified polysaccharides
WO2004064881A1 (en) * 2003-01-24 2004-08-05 Insense Limited Skin treatment formulations
US20060142684A1 (en) * 2003-04-11 2006-06-29 Shanbrom Technologies, Llc Oxygen releasing material
WO2004108065A2 (en) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
CA2529413C (en) * 2003-06-20 2014-05-27 Johnson & Johnson Medical Limited Antioxidant wound dressing materials
GB2408206B (en) * 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
GB2408207A (en) 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
US20050281890A1 (en) * 2004-06-18 2005-12-22 San Chandan K Methods and compositions for wound healing
WO2006083927A2 (en) 2005-01-31 2006-08-10 Coram Bioscience, Inc. Antimicrobial agent
FR2882595B1 (fr) * 2005-02-25 2007-05-25 Oreal Procede pour evaluer le potentiel de desactivation de radicaux libres de la peau
US8084268B2 (en) * 2005-02-25 2011-12-27 L'oreal Method of evaluating the potential of the skin for scavenging free radicals
ITMI20050881A1 (it) * 2005-05-16 2006-11-17 Anna Favre Kit diagnostico per la malattia di hirschsprung megalon congenito
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US8852558B2 (en) * 2008-03-11 2014-10-07 Materials Modification, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
US8486032B2 (en) * 2008-12-24 2013-07-16 Kci Licensing, Inc. Reduced-pressure treatment systems and methods employing debridement mechanisms
US8529528B2 (en) * 2008-12-24 2013-09-10 Kci Licensing, Inc. Reduced-pressure wound treatment systems and methods employing microstrain-inducing manifolds
US8708984B2 (en) * 2008-12-24 2014-04-29 Kci Licensing, Inc. Reduced-pressure wound treatment systems and methods employing manifold structures
EP2741788A4 (de) 2011-08-14 2015-03-25 Materials Modification Inc Verfahren und zusammensetzung zur in-situ-bildung einer künstlichen sperre zur bekämpfung von blutverlust
CA2888241C (en) 2012-10-16 2020-12-29 Surmodics, Inc. Wound packing device and methods
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
KR102668789B1 (ko) 2018-11-23 2024-05-24 (주)메디코스바이오텍 창상치료용 약학조성물
CN115381735A (zh) * 2022-08-13 2022-11-25 上海纳米技术及应用国家工程研究中心有限公司 一种用于皮肤抗氧化的水凝胶敷料及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4781921A (en) * 1986-10-06 1988-11-01 The University Of Akron Hydrogels of quadrol methacrylate polymers
JPS63207832A (ja) * 1987-02-24 1988-08-29 Asahi Chem Ind Co Ltd ポリアセタ−ル樹脂の接着性改良方法
FR2638972B1 (fr) * 1988-11-14 1990-12-14 Osteal Medical Laboratoires Ciment pour la fixation de protheses osseuses

Also Published As

Publication number Publication date
US5667501A (en) 1997-09-16
JPH08503869A (ja) 1996-04-30
GB9511571D0 (en) 1995-09-06
AU5654694A (en) 1994-07-04
GB2288736A (en) 1995-11-01
DE69328308D1 (de) 2000-05-11
WO1994013333A1 (en) 1994-06-23
CA2151246C (en) 2006-10-03
EP0673262B1 (de) 2000-04-05
GB2288736B (en) 1996-10-02
CA2151246A1 (en) 1994-06-23
EP0673262A1 (de) 1995-09-27
GB9225581D0 (en) 1993-01-27
AU679954B2 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
ATE191348T1 (de) Wundverbände
FI953490A0 (fi) Kuidut
DE60008790D1 (de) Medizinische verbände enthaltend gelartiger honig
DE69130320D1 (de) Katalysator für alpha-olefinpolymerisation und herstellung von poly(alpha)olefinen damit
DK0705269T3 (da) Titan(II)- eller zirkonium(II)-komplekser og additionspolymerisationskatalysatorer deraf.
NO952469D0 (no) Terapautisk kombinasjon som inneholder interferon
DK4893A (da) Hudpladeprodukt
DK0517890T3 (da) Bioforligelige slidbestandige overtrukne substrater
NO984467L (no) FremgangsmÕte for l°sningspolymerisasjon med dispergert katalytisk aktivator
CA2237606A1 (en) Portable wound treatment apparatus
DE69326418D1 (de) Medizinisch, hochwasserabsorbierende Polymere für Wundverbände und medizinische Binden
DE69313284D1 (de) Verfahren zur deliquifizierung und zum bleichen von einem ligenocellulosischen material
MX9606450A (es) Derivados de bencimidazolona.
ATE255915T1 (de) Dermales gerüst auf der grundlage eines neutralisierten chitosan-schwammes oder eines neutralsierten gemischten chitosan-kollagen- schwammes
TR199801365T2 (xx) �yile�me s�recinin kontrol�.
MY103869A (en) Catalyst for regulating the molecular weight distribution of ethylene polymers.
DE69600367D1 (de) Verwendung von Sulfasalazin und/oder dessen aktiven Metaboliten zur Herstellung eines Arzneimittels zur Behandlung von venöser Insuffizienz und venösen Ulcera
DE69623325D1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
SE9603284D0 (sv) New compounds
ATE234110T1 (de) Komponente b als wundheilendes mittel
DE69428276D1 (de) Insulinähnlicher wachstumfaktor ii als antitumormittel
MX9704177A (es) Material absorbente.
ATE253945T1 (de) Verwendung von wundverbänden zur behandlung von akuten wunden
TR199701679U (xx) Hipertrofik scar, keloid ve anjoma tedavisinde kullanılan giysilerde yenilik

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties